Abstract-Experiments tested the hypothesis that P2 receptor reactivity is impaired in angiotensin (Ang) II hypertensive rats fed an 8% NaCl diet (Ang IIϩHS). Juxtamedullary afferent arteriolar autoregulatory behavior was determined over a pressure range of 65 to 200 mm Hg. Arteriolar responsiveness to P2X 1 (␤,␥-methylene ATP) or P2Y 2 receptor (uridine triphosphate) activation was determined in vitro. Systolic blood pressure averaged 126Ϯ3 and 225Ϯ4 mm Hg in control and Ang IIϩHS rats, respectively (PϽ0.05). In control kidneys, ␤,␥-methylene ATP (10 Ϫ8 to 10 Ϫ4 mol/L) reduced arteriolar diameter by 8Ϯ3%, 13Ϯ5%, 19Ϯ5%, 22Ϯ6%, and 24Ϯ9%, respectively, whereas uridine triphosphate reduced diameter by 2Ϯ1%, 2Ϯ2%, 9Ϯ3%, 37Ϯ7%, and 58Ϯ7%. Autoregulation was markedly blunted in Ang IIϩHS kidneys, with arteriolar diameter remaining essentially unchanged when perfusion pressure increased to 200 mm Hg compared with a 40Ϯ2% decline in diameter observed in normal kidneys over the same pressure range (PϽ0.05). P2X 1 receptor-mediated vasoconstriction was significantly attenuated in Ang IIϩHS kidneys. ␤,␥-Methylene ATP reduced arteriolar diameter by 1Ϯ1%, 3Ϯ2%, 6Ϯ1%, 9Ϯ3%, and 7Ϯ1%, respectively (PϽ0.05), versus control rats. Similar patterns were noted when hypertensive perfusion pressures were used. Uridine triphosphate-mediated responses were unchanged in Ang IIϩHS rats compared with control, indicating preservation of P2Y 2 receptor function. Ang IIϩHS blunted P2X 1 -mediated increases in intracellular Ca 2ϩ concentration in preglomerular smooth muscle cells. Therefore, Ang IIϩHS rats exhibit attenuated afferent arteriolar responses to P2X 1 receptor stimulation. These data support the hypothesis that P2X 1 receptors are important for pressure-mediated autoregulatory responses. Impairment of P2X 1 receptor function may explain the hypertension-induced decline in renal autoregulatory capability. ) influx-dependent mechanisms. [3][4][5] Uridine triphosphate (UTP; P2Y 2 ) receptors also stimulate vasoconstriction but do so mainly through release of Ca 2ϩ from intracellular stores. 3,4 Inactivation of P2X 1 receptors blocks pressure-mediated autoregulatory vasoconstriction, 1,2 suggesting that increases in transmural pressure lead to autoregulatory vasoconstriction by ATP-dependent P2X 1 receptor activation.
P revious work indicates that ␤,␥-methylene ATP (P2X 1 ) receptors contribute importantly to pressure-mediated autoregulatory vasoconstriction of afferent arterioles. 1,2 P2X 1 receptors are ligand-gated channels that stimulate afferent arteriolar vasoconstriction through calcium (Ca 2ϩ ) influx-dependent mechanisms. [3] [4] [5] Uridine triphosphate (UTP; P2Y 2 ) receptors also stimulate vasoconstriction but do so mainly through release of Ca 2ϩ from intracellular stores. 3, 4 Inactivation of P2X 1 receptors blocks pressure-mediated autoregulatory vasoconstriction, 1,2 suggesting that increases in transmural pressure lead to autoregulatory vasoconstriction by ATP-dependent P2X 1 receptor activation.
Renal perfusion is primarily controlled by agonist-induced and pressure-mediated adjustments in preglomerular resistance. 6 Regulation of preglomerular resistance is central to the maintenance of glomerular capillary pressure. Afferent arterioles are the main vascular elements responsible for pressure-mediated autoregulatory adjustments in preglomerular resistance to regulate renal blood flow and glomerular filtration rate. 6 Autoregulatory reactivity is attenuated in several forms of hypertension, including the angiotensin (Ang) II-infused model [7] [8] [9] [10] [11] [12] [13] ; however, the mechanisms responsible for blunted autoregulatory behavior are unclear. Along with a reduced response to pressure, afferent arterioles from hypertensive rats also show blunted vasoconstrictor responses to P2X 1 receptor activation. 11, 12 Therefore, reduction of P2X 1 receptor reactivity strongly correlates with blunted autoregulatory efficiency.
This study was performed to extend the previous report 11 to determine whether afferent arteriolar autoregulatory behavior and P2X 1 receptor-mediated vasoconstriction could be eliminated in a model of salt-sensitive hypertension that includes increased dietary salt. For these studies, we combined chronic subpressor infusion of Ang II with a high-salt diet. We examined autoregulatory behavior, afferent arteriolar P1 and P2 receptor reactivity, and preglomerular smooth muscle cell Ca 2ϩ signaling. Results indicate blunted but not abolished (passive vascular behavior) autoregulatory responsiveness, coincident with reduced P2X 1 receptor reactivity and Ca 2ϩ signaling.
Methods
Please see the online Data Supplement at http://hyper.ahajournals. org for an expanded description of the methods.
Animals
Experiments were performed on male Sprague-Dawley rats weighing 225 to 250 g. Some rats received chronic Ang II infusion (60 ng/min; 14 days) by osmotic minipump, as described. 11, 12 Ang II-infused rats received an 8% salt diet. Systolic blood pressure and body weight were measured every 3 to 4 days. Animals were treated according to the National Institutes of Health Guide for the Care and Use of Laboratory Animals using procedures approved by the Medical College of Georgia Institutional Animal Care and Use Committee.
Afferent Arteriole Responses
Videomicroscopy experiments were conducted in vitro using the blood-perfused juxtamedullary nephron technique, as described. 12, 14 Sustained afferent arteriolar diameter was calculated from the average of measurements made during the final 2 minutes of each treatment period. For the autoregulatory portion, arteriolar diameters were measured during step (15-mm Hg) increases in renal perfusion pressure from 65 to 170 mm Hg in successive 5-minute periods 11 followed by a 10-minute recovery period (100 mm Hg). A separate group of kidneys underwent an autoregulatory profile that ranged from 95 to 200 mm Hg to reflect the hypertensive pressures. Then arteriolar responses to P1 or P2 agonists were determined. Afferent arterioles were exposed to increasing concentrations of ATP, ␤,␥-methylene ATP, UTP, or adenosine (10 Ϫ8 to 10 Ϫ4 mol/L), and diameter was measured.
Renal Microvascular Smooth Muscle Cell Isolation
Preglomerular microvessels were isolated from separate rats as described. 11 Dispersed cells were collected and loaded with the calcium-sensitive fluorescent probe, fura 2-acetoxymethyl ester (10.0 mol/L) for study. 
Western Blot Analysis of P2X 1 Receptor Expression in Kidney
Homogenates of renal cortex, medulla, and preglomerular microvessels were prepared using kidneys from separate control or Ang IIϩHS rats, as described. 11, 15 Results Ang IIϩHS treatment increased systolic blood pressure (225Ϯ4 mm Hg; PϽ0.05) significantly compared with normotensive control rats (126Ϯ3 mm Hg; Table; Figure S1 , available in the online Data Supplement at http://hyper. ahajournals.org). Systolic blood pressure increased similarly in all of the groups of Ang IIϩHS rats prepared for different agonist protocols (Table) . Body weights were similar across all of the groups and averaged Ϸ230 g before initiation of Ang II infusion and HS diet. Ang IIϩHS rats gained weight during the 14-day treatment period but not as rapidly as normotensive controls. By day 14, body weights averaged 292Ϯ7 g in Ang IIϩHS rats compared with 357Ϯ15 g in controls (PϽ0.05).
Autoregulatory Studies
Afferent arteriolar diameter averaged 15.7Ϯ0.5 m in control rats at 100 mm Hg (nϭ24) and decreased by 23Ϯ3% (PϽ0.05 versus control) when renal perfusion pressure increased from 65 to 170 mm Hg (Figure 1 ). In contrast, increasing perfusion pressure to 170 mm Hg in Ang IIϩHS rats reduced afferent diameter by just 9Ϯ2% (PϽ0.05 versus control group) from a control of 16.0Ϯ0.4 m (Figure 1 ). The magnitude of the pressure-mediated vasoconstrictor response declined significantly in hypertensive Ang IIϩHS kidneys compared with normotensive controls.
In separate rats, autoregulatory behavior was determined between 95 and 200 mm Hg. Baseline arteriolar diameter averaged 14.9Ϯ0.4 m in control rats, at 95 mm Hg (nϭ4), and decreased by 40Ϯ2% (PϽ0.05 versus control) when renal perfusion pressure increased to 200 mm Hg (Figure 1 
Afferent Arteriolar Responses to ATP
Responses to ATP are presented in Figure 2A . Baseline diameters were similar between the control and Ang IIϩHS groups, averaging 15.7Ϯ0.9 m (nϭ6) and 14.9Ϯ0.5 m (nϭ7), respectively. In normotensive rats, superfusion with ATP changed arteriolar diameter to 101Ϯ1%, 94Ϯ1%, 86Ϯ2%, 76Ϯ2%, and 71Ϯ5% of control diameter for ATP concentrations of 10 Ϫ8 to 10 Ϫ4 mol/L. Ang IIϩHS blunted vasoconstrictor responses to ATP, because diameter decreased only to 98Ϯ1%, 95Ϯ1%, 87Ϯ3%, 81Ϯ4%, and 85Ϯ5% of control over the same concentration range. These data demonstrate that arteriolar responses to ATP are attenuated in Ang IIϩHS kidneys.
Afferent Arteriolar Responses to P2X 1 Receptor Activation
Autoregulatory behavior is linked to P2X 1 receptor activation. 1, 2 Blunted reactivity to ATP could reflect reduced P2X 1 receptor reactivity. Arteriolar responses to the P2X 1 agonist, ␤,␥-methylene ATP are presented in Figure 2B . Baseline diameters were similar between control and Ang IIϩHS groups at a perfusion pressure of 100 mm Hg, averaging 15.8Ϯ0.2 m (nϭ5) and 16.7Ϯ0.3 m (nϭ7), respectively. In control rats, ␤,␥-methylene ATP decreased arteriolar diameter to 92Ϯ2%, 87Ϯ5%, 81Ϯ6%, 78Ϯ6%, and 76Ϯ9% of control diameter for concentrations of 10 Ϫ8 to 10 Ϫ4 mol/L. Ang IIϩHS markedly blunted the vasoconstrictor responses. ␤,␥-Methylene ATP decreased diameter to just 99.0Ϯ0.4%, 97.0Ϯ2.0%, 94.0Ϯ1.0%, 91.0Ϯ3.0%, and 93.0Ϯ1.0% of control over the same concentration range. These data indicate that afferent arteriolar responses to P2X 1 receptor stimulation are greatly attenuated in kidneys from Ang IIϩHS-treated hypertensive rats.
We also examined P2X 1 receptor reactivity in separate kidneys perfused at the hypertensive pressure (170 mm Hg; Figure 2B ). Consistent with intact autoregulatory behavior, baseline diameters were significantly lower in the control kidneys, at 12.5Ϯ0.2 m (nϭ7), compared with Ang IIϩHS kidneys, at 14.9Ϯ0.3 m (PϽ0.05; nϭ5). In control rats at 170 mm Hg, ␤,␥-methylene ATP decreased arteriolar diameter to 95Ϯ1%, 92Ϯ1%, 88Ϯ2%, 85Ϯ2%, and 83Ϯ1% of control diameter for concentrations of 10 Ϫ8 to 10 Ϫ4 mol/L. Ang IIϩHS still blunted the vasoconstrictor responses such that ␤,␥-methylene ATP decreased diameter to just 99Ϯ1%, 98Ϯ2%, 94Ϯ2%, 92Ϯ4%, and 88Ϯ5% of control over the same concentration range. Collectively, these data indicate that afferent arteriolar responses to P2X 1 receptor stimulation are greatly attenuated in kidneys from Ang IIϩHS-treated hypertensive rats perfused at normotensive or hypertensive pressures.
Afferent Arteriolar Responses to P2Y Receptor Activation
Afferent arterioles exhibit significant vasoconstrictor responses to the P2Y 2 agonists UTP and adenosine 5=-o-(3-thio triphosphate) (ATP-␥-S). 1, 3, 6 Therefore, studies were performed to determine the effect of Ang IIϩHS hypertension on arteriolar responses to UTP ( Figure 3A ). Baseline diameters at 100 mm Hg were similar between control and Ang IIϩHS groups, averaging 15.5Ϯ0.4 m (nϭ7) and 15.2Ϯ0.8 m (nϭ8), respectively. In control rats, UTP decreased arteriolar diameter to 98Ϯ1%, 98Ϯ2%, 91Ϯ3%, 63Ϯ7%, and 42Ϯ7% of control for concentrations of 10 Ϫ8 to 10 Ϫ4 mol/L. In Ang IIϩHS kidneys, arteriolar diameter declined to 100Ϯ2%, 97Ϯ3%, 89Ϯ3%, 75Ϯ7%, and 61Ϯ9% of control over the same concentration range. The magnitudes of these changes are similar to responses in control kidneys. These data indicate that afferent arteriolar responses to P2Y 2 receptor stimulation are unchanged in Ang IIϩHS hypertension.
We also examined the responses to UTP in kidneys perfused at hypertensive pressure ( Figure 3A ). Baseline diameters were significantly smaller in control kidneys compared with Ang IIϩHS groups, averaging 13.0Ϯ0.2 m (nϭ6) and 15.5Ϯ0.1 m (nϭ4), respectively, consistent with intact autoregulation. UTP reduced diameter similarly between the control and Ang IIϩHS groups at 170 mm Hg, but overall the maximum responses were smaller at hypertensive pressures than at normotensive pressures. UTP decreased arteriolar diameter to 97Ϯ1%, 95Ϯ2%, 90Ϯ3%, 83Ϯ4%, and 75Ϯ5% of control for concentrations of 10 Ϫ8 to 10 Ϫ4 mol/L in control kidneys. In Ang IIϩHS kidneys, arteriolar diameter averaged 98Ϯ1%, 96Ϯ2%, 89Ϯ3%, 79Ϯ2%, and 71Ϯ3% of control over the same concentration range. These data indicate that afferent arteriolar responses to P2Y 2 receptor stimulation are unchanged in Ang IIϩHS hypertension compared with normotensive kidneys.
Afferent Arteriolar Responses to Adenosine Receptor Activation
Adenosine influences afferent arteriolar diameter through activation of A 1 receptors and is postulated to mediate tubuloglomerular feedback responses. 16 Experiments were performed to compare arteriolar responses to adenosine in control and Ang IIϩHS rats. Baseline diameters were similar between the control (15.1Ϯ0.9 m; nϭ6) and Ang IIϩHS (15.1Ϯ0.8 m; nϭ7) groups ( Figure 3B ). In control rats, adenosine changed arteriolar diameter to 96Ϯ1%, 91Ϯ2%, 85Ϯ4%, 93Ϯ2%, and 106Ϯ4% of baseline for concentrations of 10 Ϫ8 to 10 Ϫ4 mol/L. Ang IIϩHS had only slight effects on the responses to adenosine. In these kidneys, the same concentrations of adenosine changed arteriolar diameter to 99Ϯ1%, 97Ϯ2%, 93Ϯ1%, 94Ϯ1%, and 100Ϯ2% of control. Only the response at 10 Ϫ6 mol/L in Ang IIϩHS was statistically reduced (Pϭ0.045) compared with control arterioles.
The lack of response to P2X 1 receptor stimulation cannot be attributed to complete loss of contractile ability by afferent arterioles, because 55 mmol/L of KCl treatment evoked similar vasoconstrictor responses in control (20Ϯ6%) and Ang IIϩHS (22Ϯ4%) kidneys. This response is only slightly smaller than typical responses of 33Ϯ2% that we have published previously. 3 In addition, UTP and adenosine still produced vasoconstriction similar to normotensive controls. Figure 4C and 5B). This response peaked rapidly, averaging 722Ϯ123 nmol/L (22 cells per 8 rats), then declined to a lower plateau. Spontaneous Ca 2ϩ oscillations were frequently observed during the plateau phase. In Ang IIϩHS cells, [Ca 2ϩ ] i responses were not significantly altered and averaged 552Ϯ114 nmol/L (30 cells per 9 rats).
Ca
In contrast, adenosine (1 mol/L) responses were not detectable ( Figure 5A 
Western Analysis for Changes in P2X 1 Receptor Expression
Preglomerular microvessels from both normotensive control and Ang IIϩHS rats exhibited strong P2X 1 receptor protein expression ( Figure S2 ). Densitometric analysis revealed that protein expression was similar in preglomerular microvessels from control rats (40Ϯ2 arbitrary densitometry units; nϭ6) versus microvessels from Ang IIϩHS rats (37Ϯ4 arbitrary density units; nϭ6). P2X 1 receptor protein expression was undetectable in the renal cortex and renal medulla in both normotensive and hypertensive settings.
Discussion
Autoregulatory behavior is essential for maintaining stable renal blood flow, glomerular capillary pressure, and glomerular filtration rate. Autoregulatory impairment is potentially harmful to the kidney by limiting the microvasculature's ability to protect glomeruli from harmful hypertensive pressures. 8, 9, 20 Autoregulatory efficiency is reduced in models of reduced renal mass, 21 Goldblatt hypertension, 9 Dahl saltsensitive hypertension, 10 N G -nitro-L-arginine methyl ester hypertension, 7 and Ang II hypertension, [11] [12] [13] as well as high dietary salt. 22 Although impairment of autoregulation is recognized, the mechanism(s) responsible remain unclear. The study examines afferent arteriolar reactivity to postulated autoregulatory messenger molecules and receptors to link known autoregulatory signaling pathways with functional impairment in Ang IIϩHS hypertension.
Autoregulation represents the combined influences of myogenic and tubuloglomerular feedback mechanisms. 6, 16, 20 ATP and adenosine are extracellular messenger molecules postulated to mediate autoregulatory adjustments in preglomerular resistance. ATP and adenosine vasoconstrict afferent arterioles by activating P2 and P1 (A 1 ) receptors, respectively. 1, 16, 19 The P2 receptor family is divided into 2 structurally and functionally distinct subfamilies, classified P2X and P2Y. 17, 18 P2X receptors are ligand-gated channels that function as nonselective cation channels. [17] [18] [19] P2Y receptors are metabotropic, G protein-coupled receptors that signal largely through the release of calcium from intracellular stores. 18, 19 In contrast, P1 receptors are activated by extracellular adenosine and are divided into 3 families classified as A 1 , A 2 , and A 3 receptors. 18, 19 A 1 and A 2 receptors are also G protein-coupled receptors that signal largely by inhibiting or stimulating adenylyl cyclase activity, respectively. 18, 19 Consequently, A 1 receptor activation inhibits cAMP production and evokes vasoconstriction, whereas A 2 receptor activation stimulates cAMP accumulation and evokes vasorelaxation. A 3 receptors appear to signal through modulation of [Ca 2ϩ ] i . Accordingly, we examined the impact of Ang IIϩHS on afferent arteriolar autoregulatory behavior and reactivity to P2 and P1 receptor activation.
Previous work supports the hypothesis that P2X 1 receptor activation is essential for transducing increases in perfusion pressure with afferent arteriolar vasoconstriction to produce autoregulatory resistance adjustments. 1,2 Pharmacological blockade of P2 receptors with nonselective blockers and with P2X 1 receptor-selective antagonists uniformly inhibits autoregulatory behavior. 1, 2, 13, 23 Global deletion of P2X 1 receptors inhibits autoregulation in P2X 1 knockout mice compared with wild-type littermates. 2 Accordingly, decreased afferent arteriolar reactivity to P2 receptor activation was implicated in the functional impairment of autoregulation in Ang IIϩHS rats. ATP is postulated as the endogenous ligand for renal microvascular P2 receptors, so we determined the arteriolar response to P2 receptor stimulation with ATP. Results indicate that arteriolar responsiveness to P2 receptor activation by ATP is blunted in Ang IIϩHS rats compared with normotensive rats similar to Ang II hypertension alone. 11 This impairment is consistent with impaired autoregulation but does not differentiate which P2 receptor subtype(s) are involved. Interestingly, this impairment is not exacerbated by the addition of high salt to the hypertensive setting.
Experiments were conducted to assess the impact of Ang IIϩHS on afferent arteriolar reactivity to P2X 1 receptor activation. We selected ␤,␥-methylene ATP as an agonist with high selectivity for P2X 1 receptors and some ability to bind to P2X 3 receptors. 17 Current and previous work clearly indicate strong P2X 1 receptor expression by the preglomerular microvasculature, 11,24 -26 but P2X 3 receptor expression by afferent arterioles is not established. In preliminary experiments, we could not detect P2X 3 receptor protein by Western blot in preglomerular microvessels of normotensive animals (data not shown). Lewis and Evans 26 report "barely detectable" P2X 3 immunostaining of small intrarenal arteries but did not report on afferent arterioles. Turner et al 25 did not detect P2X 3 immunostaining in renal arterioles. Finally, Harhun et al 27 detects the PCR product for P2X 1 and P2X 4 while not detecting gene expression for P2X 2 , P2X 3 , P2X 5 , or P2X 7 receptors. These data suggest that P2X 1 receptors are the primary mechanisms by which ␤,␥-methylene ATP vasoconstricts afferent arterioles. In the current report, arteriolar vasoconstriction to ␤,␥-methylene ATP was blunted in kidneys from Ang IIϩHS rats compared with normotensive controls. Blunted reactivity was observed regardless of whether the kidneys were perfused at normotensive or hypertensive pressures, suggesting an inherent decline in P2X 1 receptor signaling. These same kidneys also exhibited impaired autoregulatory behavior, supporting the hypothesis that P2X 1 receptors mediate pressure-dependent autoregulation. These data further suggest that impaired autoregulation in Ang IIϩHS rats reflects impaired P2X 1 receptor signaling.
Afferent arterioles also respond to the P2Y 2 receptor agonist UTP and to the P 1 receptor agonist adenosine. Arteriolar responses to these agonists were essentially unchanged in Ang IIϩHS rats compared with normotensive controls despite impaired autoregulation. Interestingly, P2Y 2 -mediated vasoconstriction was uniformly blunted in control and Ang IIϩHS kidneys when perfused at hypertensive pressures. The mechanism for this remains unclear, but because the decline in function was similar in both the normotensive and hypertensive groups, it cannot explain the decline in autoregulatory efficiency. Compared with a previous study with Ang II hypertensive rats on a normal salt diet, 11 the response to adenosine was attenuated at the 1.0 mol/L concentration. The importance of this is unclear, but reduced adenosine reactivity cannot explain hypertension-induced impairment of autoregulatory efficiency, because adenosine-reactivity was normal in Ang II hypertension alone, where autoregulation was clearly impaired. The addition of salt to the hypertensive sequence may have a direct effect on adenosine receptor expression/function independent of blood pressure. Overall, these data support the postulate that autoregulation is mediated primarily by P2X 1 receptors with P2Y 2 receptors or P1 receptors not making major contributions to this pressuredependent response.
Exactly how hypertension impairs autoregulatory behavior is unclear. Chronic P2 receptor blockade in vivo prevents mesangial cell proliferation and vascular thickening of afferent arterioles of Ang II hypertensive rats, despite having no detectable effect on blood pressure, renin, or renal Ang II content. 28 Recent studies suggest that local inflammation may influence arteriolar function and inhibit autoregulatory efficiency. 12 In those studies, simultaneous treatment with the broad-spectrum anti-inflammatory agent pentosan polysulfate provided protection against autoregulatory impairment in Ang II hypertensive rats without changing the progression or
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magnitude of the hypertension. 12 Pentosan polysulfate also preserved arteriolar reactivity to P2X 1 stimulation with ␤,␥-methylene ATP. In other studies, pentosan polysulfate is renoprotective in reduced renal mass hypertension, and it restored glomerular hemodynamics, independent of arterial hypertension. 29 -31 Transient exposure to chronic Ang II infusion confers greater salt sensitivity and interstitial inflammation, 32 suggesting that induction of Ang II hypertension elicits inflammation in the kidney that negatively impacts microvascular function. They also suggest that inflammation is linked to renal injury imposed by adding salt to a hypertensive setting. Collectively, it is possible that initiation of intrarenal inflammation is directly linked to impaired P2X 1 receptor function. We reported previously that P2X 1 receptor expression appears normal in kidneys from Ang II hypertensive rats. 11 The current report confirms and extends that observation by indicating that P2X 1 receptor expression was also unchanged when salt was combined with Ang II-infused hypertension. The explanation for impaired P2X 1 receptor reactivity in the face of relatively normal P2X 1 receptor expression is unclear. Vial and coworkers 33, 34 reported that P2X 1 receptors are influenced by their association with lipid rafts. Disruption of lipid rafts renders P2X 1 receptors dysfunctional. It is conceivable that hypertension, with or without excess salt, could alter the microvascular lipid raft environment and lead to reduced P2X 1 receptor functionality despite normal levels of P2X 1 receptor protein expression. Similarly, it is possible that perivascular inflammation could negatively impact P2X 1 receptor association with lipid rafts and reduce P2X 1 receptor activity. Alternatively, P2X 1 receptor trafficking could be disrupted in hypertension and lead to reduced P2X 1 receptor expression in the sarcolemma. A fourth possibility is that signaling downstream of P2X 1 receptor activation is compromised. Preglomerular microvascular P2X 1 receptors signal through calcium and rho-kinase activity. [3] [4] [5] 11, 14 Rho-kinase inhibition blocks autoregulation and P2X 1 receptor-mediated vasoconstriction while having a more modest effect on P2Y 2 receptor-mediated vasoconstriction. 14 More extensive studies are required to help resolve these possibilities. P2X 1 receptor-dependent Ca 2ϩ signaling is impaired in Ang II hypertensive rats, so alterations in downstream signaling pathways/events are potential explanations for the blunted autoregulatory and P2X 1 receptor-mediated events. 11 Consistent with previous findings, Ca 2ϩ signaling responses for ATP and P2X 1 receptor activation are markedly impaired, but the degree of impairment is not notably different from that seen with Ang II infusion alone. 11 Importantly, blunted Ca 2ϩ signaling responses are unique to the P2X 1 receptor, because responses to UTP-dependent P2Y 2 receptor activation and KCl depolarization were unchanged. In addition, the response to 10 mol/L of ATP, which activates P2X and P2Y receptors, was also significantly blunted. This may reflect signaling loss of the P2X Ca 2ϩ component and retention of the P2Y portion of the overall ATP-dependent response. These data support a key role for P2X 1 6 lack of a Ca 2ϩ response to adenosine calls into question the suitability of adenosine as a major signaling molecule mediating overall autoregulatory control.
This study demonstrates that Ang IIϩHS hypertension significantly impairs autoregulation of rat juxtamedullary afferent arterioles. Coincident with this impairment is a decline in afferent arteriolar reactivity to ATP and to P2X 1 receptor activation, whereas reactivity to the P2Y 2 agonist UTP or to the P1 receptor agonist adenosine is essentially unchanged. Importantly, autoregulatory impairment was manifested at perfusion pressures as high as 200 mm Hg, eliminating the possibility that these hypertensive rats merely operate with a right-shifted pressure-flow relationship. In addition, refractory arteriolar reactivity to P2X 1 receptor stimulation was apparent at both normotensive and hypertensive pressures, whereas KCl-mediated vasoconstriction was clearly evident. Decreased reactivity to P2X 1 receptor activation cannot be attributed to decreased P2X 1 receptor expression, because Western blot analysis reveals no detectable difference in P2X 1 receptor protein levels in preglomerular microvascular tissue, but Ca 2ϩ signaling responses to P2X 1 activation are markedly blunted. This study extends previous reports of impaired autoregulatory behavior in hypertensive models by implicating decreased afferent arteriolar reactivity to P2X 1 receptor activation as a causal link.
Perspectives
The impact of hypertension on renal microvascular function is an important variable in the progression to hypertensive renal injury. Efficient autoregulatory control protects healthy kidneys from barotrauma that comes from acute elevations in renal perfusion pressure. Hypertension, however, brings chronic elevations in blood pressure that impairs microvascular autoregulatory function and microvascular reactivity to some vasoactive agents and leads to glomerular hypertrophy and injury. Resolving the mechanisms that underlie this loss of function will facilitate our ability to design therapeutic interventions that will prevent renal decline early in the hypertensive progression and may permit reversal of existing impairment. This would indeed provide an improved quality of life and prolong normal renal function in afflicted patients.
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